Acute and chronic suppression of leukotriene B4 synthesis EX vivo in neutrophils from patients with rheumatoid arthritis beginning treatment with methotrexate

Arthritis & Rheumatism

Volumn 35, Issue 4, 1992, Pages 376-384

  Sperling, Richard I ^a   Benincaso, Anthony I ^a   Anderson, Ronald J ^a   Coblyn, Jonathan S ^a   Austen, K Frank ^a   Weinblatt, Michael E ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONATE 5 LIPOXYGENASE; CALCIUM IONOPHORE; LEUKOTRIENE B4; METHOTREXATE; THROMBOCYTE ACTIVATING FACTOR;

ADULT; AGED; ARACHIDONIC ACID METABOLISM; ARTICLE; CLINICAL ARTICLE; DRUG EFFECT; FATTY ACID OMEGA OXIDATION; FEMALE; HUMAN; IMMUNOREACTIVITY; LEUKOCYTE ACTIVATION; MALE; MONOCYTE; NEUTROPHIL; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS;

ADULT; AGED; ARACHIDONATE 5-LIPOXYGENASE; ARTHRITIS, RHEUMATOID; CHEMOTAXIS, LEUKOCYTE; HUMAN; LEUKOTRIENE B4; METHOTREXATE; MIDDLE AGE; MONOCYTES; NEUTROPHILS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TIME FACTORS;

EID: 0026695292     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.1780350403     Document Type: Article

References (42)

1. A controlled two‐centre trial of parenteral methotrexate therapy for refractory rheumatoid arthritis
2. Efficacy of lowdose methotrexate in rheumatoid arthritis
3. Weekly pulse methotrexate in rheumatoid arthritis
4. Comparison of low‐dose or pulse methotrexate and placebo in the treatment of rheumatoid arthritis: a controlled clinical trial
5. Measurement of immunologic and inflammatory responses in vitro in rheumatoid arthritis patients treatest with methotrexate
6. Immunologic studies of rheumatoid arthritis patients treated with methotrexate
7. Methotrexate in rheumatoid arthritis (editorial)
8. Temporary remissions in acute leukemia is children produced by a folic acid antagonist, 4‐aminopteroyl‐glutamic acid (aminopterin)
9. Immunosuppressive and antiinflammatory properties of cyclophosphamide, azathioprine, and methotrexate
10. 4‐induced intraepidermal accumulation of polymorphonuclear leukocytes
11. 5a‐induced skin response in patients with psoriasis
12. 5a
13. The effect of methotrexate and hydroxyurea on neutrophil chemotaxis
14. Inhibition of neutrophil chemotaxis in methotrexate treated rheumatoid arthritis patients
15. 4 synthesis in neutrophils from patients with rheumatoid arthritis by a single oral dose of methotrexate
16. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis
17. Effects of exogenous arachidonic, eicosapentaenoic, and docosahexaenoic acids on the generation of 5‐lipoxygenase pathway products by ionophore‐activated human neutrophils
18. The effect of N‐3 polyunsaturated fatty acids on the generation of PAF‐acether by human monocytes
19. The development of sensitive and specific radioimmunoassays for leukotrienes
20. Antibody to platelet activating factor (1‐O‐alkyl‐2‐acetyl‐sn‐3‐phosphocholine; PAF)
21. Effects of dietary supplementation with marine fish oil on leukocyte lipid mediator generation and function in rheumatoid arthritis
22. 5 and the double lipoxygenase product
23. Effect of dietary enrichmene with eicosapentaenoic and docosahexaenoic acids on in vitro neutrophil and monocyte leukotriene generation and neutrophil function
24. Remodeling of arachidonatecontaining phosphoglycerides within the human neutrophil
25. Potential source(s) of arachidonate used for the synthesis of leukotrienes by the human neutrophil
26. 2
27. 4 synthesized by polymorphonuclear leukocytes
28. 4
29. 4 in human lymphocytes
30. 4 in human T‐cell lines
31. Mediation of local homeostasis and inflammation by leukotrienes and other mast celldependent compounds
32. 4 enhances activation, proliferation, and differentiation of human B lymphocytes
33. 4 potentiates the expression and release of FCRII/CD23, and proliferation and differentiation of human B lymphocytes induced by IL‐4
34. Functional characterization of synthetic leukotriene B and its stereochemical isomers
35. 4 toward rabbit neutrophils
36. Studies on the effect of low dose methotrexate on rat adjuvant arthritis
37. Implications of biochemical, cytokinetic, pharmacologic and toxicologic relationships in the design of optimal therapeutic schedules
38. Identification and isolation of a membrane protein necessary for leukotriene production
39. MK866, a potent and specific leukotriene biosynthesis inhibitor blocks and reverses the membrane association of 5‐lipoxygenase in ionophore‐challenged leukocytes
40. Formation of methotrexate polyglutamates in purified myeloid precursor cells from normal human bone marrow
41. Methotrexate kinetics in myeloid bone marrow cells and peripheral neutrophils